These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20880129)

  • 1. Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass.
    Ashrafian H; Athanasiou T; Li JV; Bueter M; Ahmed K; Nagpal K; Holmes E; Darzi A; Bloom SR
    Obes Rev; 2011 May; 12(5):e257-72. PubMed ID: 20880129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bariatric surgery: unstressing or boosting the beta-cell?
    Mingrone G; Castagneto M
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():130-42. PubMed ID: 19817795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
    Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
    Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bariatric surgery: effects on glucose homeostasis.
    Rubino F
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):497-507. PubMed ID: 16778583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study.
    Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
    J Surg Res; 2007 Oct; 142(2):295-300. PubMed ID: 17640666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
    Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
    Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
    Mingrone G
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
    Gumbs AA; Modlin IM; Ballantyne GH
    Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
    Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
    Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
    Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?
    Andreelli F; Amouyal C; Magnan C; Mithieux G
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):499-507. PubMed ID: 20152734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catabolic effects of gastric bypass in a diet-induced obese rat model.
    Guijarro A; Kirchner H; Meguid MM
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):423-35. PubMed ID: 16778572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percentage of excess BMI lost correlates better with improvement of metabolic syndrome after Roux-en-Y gastric bypass in morbidly obese subjects: anthropometric indexes and gastric bypass.
    Rossi M; Serpa Neto A; Rossi FM; Amarante RD; Alcântara GC; da Silva RB; Regina PF
    Surg Obes Relat Dis; 2009; 5(1):11-8. PubMed ID: 18996755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New insight into old disease: potential treatment of type 2 diabetes mellitus by bariatric surgery].
    Keidar A; Schweiger C; Raz I
    Harefuah; 2010 Feb; 149(2):95-8, 124. PubMed ID: 20549927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed description of early response of metabolic syndrome after laparoscopic Roux-en-Y gastric bypass.
    Ali MR; Fuller WD; Rasmussen J
    Surg Obes Relat Dis; 2009; 5(3):346-51. PubMed ID: 19362060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes.
    Zervos EE; Agle SC; Warren AJ; Lang CG; Fitzgerald TL; Dar M; Rotondo MF; Pories WJ
    J Am Coll Surg; 2010 May; 210(5):564-72, 572-4. PubMed ID: 20421005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp.
    Lima MM; Pareja JC; Alegre SM; Geloneze SR; Kahn SE; Astiarraga BD; Chaim EA; Geloneze B
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3871-5. PubMed ID: 20484482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery.
    Mingrone G; Castagneto-Gissey L
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):518-23. PubMed ID: 20152737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
    Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
    J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.